KIR3DL1 and COVID-19: To understand the role of diverse KIR+HLA+ gene combinations in NK cell defense to SARS-CoV-2, we studied the host genetic polymorphism of KIR and their cognate HLA class I ligands in hospitalized COVID-19 patients and the general population.